Description: Predictive analytics projects in the life insurance industry are oftentimes set up as research ideas leading to intangible or unusable results for the practicing actuary. What if you could change that? What if the research turned into development and practical use through leveraging valuable resources properly? Learn how to structure predictive analytics projects, and about the project team, so there will be actionable takeaways for the business unit. Specific areas of value for you include underwriting, experience studies, assumption-setting, and product development. Watch as presenters talk through real case studies on turning a predictive analytics project into workable solutions rather than a resource drain, an unclear goal, or a misunderstood business need, which are some of the pitfalls of a poorly planned project.

Description: The CIA, CAS Institute (iCAS) and the Society of Actuaries (SOA) are joining forces once again to launch the Predictive Analytics Hack-A-Thon!

Description: Discover the key components of value-based care (VBC) contracts and their impact on provider credibility. Learn about benchmarks, measurement period results, and the unique challenges providers face in managing insurance risk. Gain insights into reducing costs and aligning financial incentives in the US healthcare market.

Description: Insurance carriers today must balance a multitude of factors to remain relevant and innovate- -process improvements and efficiency (automated or traditional); -customer experience (less intrusive, more data); -distribution (aging traditional, product focus, emerging opportunities); and -mortality. While these factors are not new, true innovation in these areas require a convergence of engagement among actuaries, underwriters and data scientists to determine the specific pain points and appreciate both the benefits and consequences of various paths. Explore examples of how best to approach these topics, engage different disciplines, avoid pitfalls and ensure a holistic view. Real life examples and lessons learned will be shared during this session.

Description: Almost half of recent FDA approvals have been for orphan drugs. This trend is expected to continue in 2023. Orphan drugs are priced more than 30 times higher than non-orphan drugs, therefore their cost burden in aggregate has the potential to overwhelm the budgets of payers, especially that of smaller health plans. Hear how the cost impact analysis for smaller health plans require different considerations than for a larger health plan when modeling the impact of rare diseases.

Description: Reunite with members and non-members in the China actuarial community to discuss recent topics and related issues in areas such as macroeconomic sharing, IFRS 17, product strategy, cross-border communication and discussion, and more. Advance your career through learning and networking opportunities, and share your experiences in the finance and insurance industries, as well as other fields related to actuarial science.

Description: Hop into a panel discussion between InsurTech Advisory Council and a startup, followed by a demo of life event prediction and analyses with multiple applications across financial services. You will also learn about: the SOA office hours program and member participation, the startup ecosystem filled with incubators, company contests, opportunities and outcomes, how to build a data set providing additional insights for customization and enhanced user experience, and - actuaries' engagement with startup strategic advisory boards.

Description: An introductory article describing how Bayesian statistics has evolved over the past 20 years and why it offers the actuarial discipline powerful tools to better understand and manage risk. Compared with traditional (frequentist) and black-box (machine learning) approaches, Bayesian analysis provides explainable models focused on distributions of estimates instad of simply point estimates.

Description: Pandemics are a main driver of losses for both life and non-life (re-)insurance. Until COVID-19, risk assessment mostly relied on a few historic examples, most importantly the Spanish flu. The COVID-19 pandemic has shown that other pathogens (namely the coronaviruses) need to be taken into account. Also, modern societies and governments drastically respond to novel threats and implement measures such as social distancing, mask mandates, and lockdowns. Besides the properties of the pathogen itself, these reactions and the medical progression (namely the development of vaccines) are key influences on the course of a pandemic, and thus also the resulting outcomes. To account for the new insights, join us as we take a look at a stochastic, age-structured compartmental model that is calibrated on recent pandemics with several parameters sets to model different levels of reaction speed and stringency between groups of countries. Other important factors also must be defined in close collaboration with experts. Get ready to explore the development of a model and framework that can provide potential outcomes to be used as the basis to derive both summary and tail statistics to assess pandemic risk and help price complex deals.

Description: Artificial Intelligence (AI) has become a key component of the insurance landscape and getting full value from an AI depends on much more than simply building the model. Please join us to hear the challenges and potential solutions around successfully deploying an AI-driven initiative within an organization. Hear from panelists as they describe the human impacts of model implementation, how to assess a model for effectiveness and (lack of) bias, and detail the journey of implementing AI-driven underwriting models at a large insurance company.